Ceramic hydroxyapatite coating on titanium implants drives selective bone marrow stromal cell adhesion.
The aim of this study was to determine the cell characteristics that regulate implant osseointegration. The heterogeneity of bone marrow stromal cells obtained from 11 donors was assessed by measuring the expression of a large panel of adhesion molecules. Large differences in expression of adhesion molecules were detected depending on the culture conditions used. Cells cultured in fetal bovine serum induced the expression of different adhesion molecules from cells cultured in human serum. Donor-to-donor variation was determined by measuring the expression of adhesion molecules for stromal cells obtained from different donors that were processed identically. Fat adherent cells but also loose bone marrow cells showed large differences in expression of some but not all adhesion molecules. The flow cytometric data demonstrated large heterogeneity in expression of adhesion molecules, and this heterogeneity was influenced by culture conditions and varied from donor to donor. This demonstrates that the implant encounters different cell types, which could lead to different levels of integration. Surprisingly, in vitro only a subfraction of bone marrow stromal cells attached to titanium coated with ceramic hydroxyapatite. Adaptation of all cell types present in heterogeneous bone marrow to a coated surface is apparently not possible. Differential binding was not caused by aberrant staining of the stromal cells as the results were confirmed with bone marrow cells obtained from transgenic GFP mice. These results demonstrate that hydroxyapatite ceramics are selective in cell recruitment from the bone marrow, explaining the differences found in vivo for these coatings compared with titanium.
Torensma
Ruurd
R
Department of Tumor Immunology, UMC Nijmegen, Nijmegen, the Netherlands. R.Torensma@ncmls.kun.nl
ter Brugge
Petra J
PJ
Jansen
John A
JA
Figdor
Carl G
CG
D000818:Animals; D001854:Bone Marrow Cells / Q000187:drug effects* / Q000378:metabolism*; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology*; D015815:Cell Adhesion Molecules / Q000096:biosynthesis*; D002478:Cells, Cultured; D020099:Coated Materials, Biocompatible / Q000494:pharmacology*; D003470:Culture Media; D017886:Durapatite / Q000494:pharmacology*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D017154:Stromal Cells / Q000187:drug effects / Q000378:metabolism; D014025:Titanium
D015815:Cell Adhesion Molecules; D020099:Coated Materials, Biocompatible; D003470:Culture Media; D017886:Durapatite; D014025:Titanium